Fritextsökning
Innehållstyper
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Iddo Leshem tar sig an Norden
Iddo Leshem har börjat sin nya roll som general manager för Bristol-Myers Squibb Norden.
-
Investeraren: "Våra bolag måste ha en plan för USA"
Karolinska Development vill att deras bolag ska ha en chans på den mer lönsamma marknaden i USA.
-
Hey there Summer Eriksson......
.....biomedical analysist at Akademsika sjukhuset in Uppsala. Why are you here at Biotech Forum and Scanlab?
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Ny teknik kan upptäcka alzheimer tidigare
Detektion av specifika former av proteinet tau i blodprover kan ge tidigare diagnostik av personer med alzheimer, redan innan de första symptomen uppstår.
-
A smart company takes care of its best
Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Här är det bäst att arbeta
Den amerikanska nättidningen Business Insider har släppt sin årliga ranking över de bästa arbetsplatserna i USA. 20 procent av dem finns inom hälso- och sjukvårdssektorn.
-
Microwave reactor for use in various synthesis applications
The Monowave 300 microwave reactor offers 850 watts of power for a variety of synthesis applications.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
Fat cells' reaction differs with body weight
The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...
-
Samuel Lagercrantz: Framgången kommer efter många misslyckanden
De allra flesta av de idéer och strategier mot covid-19 som man nu jobbar med kommer att gå i stöpet, men det kan räcka med att en enda fungerar, skriver Samuel Lagercrantz.
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Vad händer inom bioprocess närmaste fem åren?
New horizons in bioprocessing and biologics är ett tekniskt möte för de insatta, men vi passar på att fråga. Vad händer inom levande läkemedel närmaste fem åren?
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Harmony prevents dementia
People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.
-
Schizophrenia and bipolar disorder are relatives
Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.